Drug-coated balloon enhanced stenting for complex left main disease
Part of Heart & circulation clinical trials.
This trial tests if using a drug-coated balloon (a balloon that slowly releases medicine to keep the artery open) improves results after placing a standard stent in the left main coronary artery (the main pipe supplying blood to the heart) and its first two branches. It may help people with complex narrowing in that area who have not had prior stenting there.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your left main coronary artery must have narrowing (stenosis) that affects the main branch and both of its first two branches (LAD and LCx) in a specific pattern (Medina 1,1,1 or 0,1,1).
- The left main artery must be 6 millimeters or smaller in diameter.
- Both the LAD and LCx arteries must be larger than 2.75 millimeters in diameter (estimated by eye on angiogram).
- You must not have had a prior stent procedure in the left main bifurcation area.
- You must not have a complete blockage (chronic total occlusion) in the LAD or LCx arteries.
- You must be 18 or older, not pregnant or breastfeeding, and able to take blood-thinning medications for at least 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares a new type of “drug-eluting” stent (a tiny scaffold that slowly releases medicine) and a single blood-thinner plan versus the usual two-drug blood thinner plan after stent placement in the left main coronary artery. It aims to see if the simpler plan can work while keeping the stent safe.
This trial studies a new way to treat blockages in the left main coronary artery using a drug-coated stent. It aims to find out if a careful approach with a single stent and temporary side-branch support works well for people with heart disease.
This trial tests a special balloon coated with a drug (sirolimus) to treat blockages in small heart arteries. If the balloon is successful, it may help keep the artery open without needing a permanent stent.
This trial studies whether a drug-coated balloon can treat certain coronary artery narrowings in adults with chronic (long-term) coronary disease. It may help prevent re-narrowing after the procedure for people whose tests show the blockage is significant and needs treatment.
This trial compares two ways to open a blocked artery that splits into two branches (a bifurcation): using a balloon coated with medicine (drug-coated balloon, or DCB) versus a drug-eluting stent (DES). The goal is to see which approach works better for patients with this type of blockage.
This trial compares two different ways of placing stents in the main heart artery on the left side and its first branch. It aims to see which method works better for people with blockages at this critical junction.
Hear when a new Left Main Coronary Artery Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.